Company Filing History:
Years Active: 1995-1996
Title: The Innovations of George W. Belenduik
Introduction
George W. Belenduik is a notable inventor based in Potomac, MD, who has made significant contributions to the field of pharmaceutical technology. With a total of three patents to his name, he has focused on developing advanced drug delivery systems that enhance the efficacy of pharmaceutical agents.
Latest Patents
Belenduik's latest patents include a sustained-release drug delivery system. This innovative composition features a highly soluble pharmaceutical agent, such as selegiline, within a pharmaceutical carrier that comprises a hydrophilic polymer dispersed in a hydrophobic matrix. This design creates a hydrophilic microenvironment in a hydrophobic matrix by incorporating hydrophilic polymers. Additionally, a binder, preferably a polyhydroxylated compound, can also be included. Another significant patent is for multilamellar drug delivery systems. This preparation includes a pharmaceutical agent incorporated into particles that consist of a core formed from either a hydrophilic material, a hydrophobic material, or a hydrophobic emulsion or dispersion. The core is surrounded by an alternating sequence of hydrophilic and hydrophobic layers, creating a hydrophilic/hydrophobic interface between the core and each succeeding layer.
Career Highlights
Belenduik has established himself as a key figure in the pharmaceutical industry through his work at Pharmavene, Inc. His innovative approaches to drug delivery systems have positioned him as a leader in the field, contributing to advancements that improve patient outcomes.
Collaborations
Throughout his career, Belenduik has collaborated with esteemed colleagues such as Edward M. Rudnic and John A. McCarty. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
George W. Belenduik's contributions to pharmaceutical technology through his patents and collaborations highlight his commitment to advancing drug delivery systems. His work continues to impact the industry positively, paving the way for future innovations.